In this activity, discover new insights and real-world evidence for improved patient outcomes in recurrent/metastatic head and neck squamous cell carcinoma from Dr. Assuntina G. Sacco, Associate Professor of Internal Medicine at the University of California, San Diego Health. Learn about differing therapeutic strategies based on tumor location and stage, human papillomavirus (HPV) status, the need to preserve surrounding organs and tissues, impacts on quality of life, and more. Start the activity now!

In this Virtual Tumor Board, discover strategies for building comprehensive care plans for patients with esophagogastric cancers from Dr. Jaffer Ajani, Professor of Gastrointestinal Medical Oncology at MD Anderson Cancer Center; Dr. Lei Zhao, Assistant Professor of Pathology at Brigham and Women's Hospital; and Dr. Kelley Rone, Advanced Practice Nurse in Gastrointestinal Oncology at the Mayo Clinic. Start the activity now to hear their case-based discussion for the multidisciplinary team!

This case-based discussion brings together two leading experts, Anne Chiang, MD, PhD, Associate Professor of Medicine, and Henry Park, MD, MPH, Chief of the Thoracic Radiotherapy Program, both at Yale School of Medicine, who will examine recent clinical advances and new opportunities in the management of SCLC and discuss key clinical questions engendered by recent advances in treatment and the need for individualized care. Start the activity now.

This expert-led discussion presented by Kathleen D. Burns, MSN, AGACNP-BC, OCN^®, Nurse Practitioner, Division of Genitourinary Medical Oncology, City of Hope Comprehensive Cancer Center, will explore various topics relevant to the treatment of metastatic CRPC, including diagnosis, staging, and the latest clinical trial results. She will also highlight the management of drug interactions and adverse events related to novel therapies. Start now!

This podcast episode from i3 Health, presented by Ariela Noy, MD, and Matthew Matasar, MD, of Memorial Sloan Kettering Cancer Center, will explore how to determine when marginal zone lymphoma (MZL) treatment should be initiated and will discuss the latest research on therapeutic strategies and their application in the clinic. Listen now!

This expert-led discussion presented by Aaron Goodman, MD, Hematologist/Oncologist and Associate Professor of Medicine at UC San Diego Health provides the latest insights on diagnosing T-cell lymphoma, including subtypes; efficacy and safety data for novel agents; tailoring treatment plans to individual patients; applying strategies to manage symptoms and optimize a patient’s quality of life; and much more! Start the activity now!

CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions.

VTE is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death. This online activity reviews signs and symptoms, risk assessment, and supportive care interventions.

Pain is among the most debilitating symptoms cancer patients experience. This online activity reviews the pathophysiology of cancer pain and scientific principles of pain management, assessment, and emerging concepts in pharmacological management.

Studies have shown that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. This activity reviews recent advances in the management of cancer teatment-induced cardiotoxicity.

Once it has metastasized to the skeletal system, cancer often negatively affects bone health, leading to pain, fractures, hypercalcemia, and nerve compression. This online activity reviews interventions to reduce morbidity and mortality of bone complications in patients with cancer.

This case-based podcast presented by i3 Health brings together two leading experts, Anne Chiang, MD, PhD, Associate Professor of Medicine, and Henry Park, MD, MPH, Chief of the Thoracic Radiotherapy Program, both at Yale School of Medicine, who will examine recent clinical advances and new opportunities in the management of SCLC and discuss key clinical questions engendered by recent advances in treatment and the need for individualized care. Start the activity now.